SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company will hold an investor conference call to discuss upcoming business opportunities and its agreement with one of the world’s premiere research laboratories. The call, which will be open to all investors, will be held on Wednesday, December 2nd at 4:30 EST. Interested parties should contact the Company at info@biomagneticsbmgp.com for invite details.
